Verily, Lumea partner to advance digital pathology in prostate cancer March 22, 2022 Auto Bot Disruptors 0 Alphabet’s life sciences arm, Verily, is partnering with the digital pathology platform Lumea to improve the objectivity and efficiency of prostate cancer diagnosis, prognosis and therapy selection.